Real-Time Payer & Provider
Digital Engagement
MAVA® connects life sciences teams with targeted payer and provider stakeholders through structured digital engagement, advisory boards, and insight programs.
The platform helps teams test assumptions, understand access dynamics, and gather feedback before key pricing, evidence, coverage, contracting, and messaging decisions are finalized.
Through MAVA®, teams can move from broad market access questions to clearer strategic direction in days, not months.
Measure. Assess. Validate. Accelerate.
MAVA® is built around a structured insight framework that helps teams move from market questions to more confident decisions through digital stakeholder engagement.
Measure
Capture payer, provider, and market stakeholder perspectives on access dynamics, clinical decision-making, reimbursement barriers, and value drivers through structured engagement.
Assess
Analyze feedback to identify access risks, evidence gaps, payer/provider expectations, and strategic opportunities.
Validate
Test assumptions directly with targeted stakeholders before pricing, coverage, evidence, contracting, or messaging decisions are finalized.
Accelerate
Move from stakeholder feedback to clearer market access direction with insights delivered quickly enough to inform active strategy decisions.
Market Access Questions MAVA® Helps Teams Answer
MAVA® helps teams pressure-test the assumptions behind launch planning, pricing, value strategy, coverage, contracting, and pull-through execution.
Value & Price Potential
How will payers evaluate the value of a new therapy?
What value drivers matter most across payer and provider stakeholders?
What evidence is needed to support the intended price and access strategy?
Payer and Provider Segmentation
Which payer, provider, IDN, GPO, or specialty pharmacy segments matter most?
How do expectations differ by stakeholder type, channel, or geography?
Where are the greatest access barriers likely to emerge?
Access Requirements
What is needed to achieve the intended access plan?
What coverage, reimbursement, or utilization management requirements should teams anticipate?
Which evidence gaps may create risk during launch or contracting?
Positioning and Value Communication
What is the clearest payer value proposition?
How should HEOR, clinical, economic, and real-world evidence be communicated?
What messages resonate most with access decision-makers?
Pricing and Contracting Strategy
What pricing and contracting strategy is most viable?
How will stakeholders respond to rebate, gross-to-net, and contracting scenarios?
What access tradeoffs should be evaluated before finalizing strategy?
Pull-Through and Optimization
How can teams improve access pull-through after strategy is set?
What field communication, account planning, and stakeholder education are needed?
Where should teams monitor access signals over time?
Decision Tools Built on
MAVA® extends digital stakeholder engagement into decision tools for pricing sensitivity, value assessment, rebate strategy, contracting performance analysis, and market access pull-through planning.
.png)
Market Access Global Reach: 5,000+ Advisors
Global Reach:
eMAX Health Market Access Research Panel by Location
US | Canada | Brazil | UK | Spain | France | Germany | Italy | Sweden | China | Japan | Australia
eMAX Health Advisors
US Payers
-
National/Regional Carriers
-
Pharmacy Benefit Managers
-
Plan Sponsors/Employer Groups
-
Accountable Care Organizations
-
Integrated Delivery Network
Global Payers and Stakeholders
-
HTA Committee Members and Advisers (e.g., NICE)
-
Payer scientific and economic advisers
-
EU-5, Asia, Nordics, etc.
Providers
-
Primary Care
-
Specialist
-
Retail Pharmacies
-
Specialty Pharmacies
-
Hub Pharmacies
MAVA®
Advisory Boards
& Expert Network
MAVA® enables structured digital engagement with payer and provider stakeholders through advisory boards, targeted insight programs, expert networks, and digital research.
These engagements give life sciences teams direct perspective on access, reimbursement, clinical decision-making, coverage dynamics, market trends, and stakeholder expectations before key strategy decisions are finalized.
Qualified payer and provider professionals may also participate in MAVA® advisory opportunities and contribute expertise to market access research.
From Digital Stakeholder Insight to Market Access Action
MAVA® helps life sciences teams capture real-time payer and provider perspective before key market access decisions are finalized. Those insights can also inform downstream strategy, including account planning, payer engagement, pull-through priorities, and field team alignment.
As eMAX Health Systems expands its AI-enabled capabilities, MAVA® may also support more proactive monitoring of access signals, stakeholder feedback, and market access decision needs over time.
For teams that need support beyond insight generation, eMAX Health Systems can help translate MAVA® findings into broader market access strategy and execution planning.
